trial · primary record
VRT106 for injection
Diffuse Midline Glioma, H3 K27M-Mutant
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 10 |
| Primary completion | 2028-12-31 |
| Primary endpoint | Disease Control Rate |
| Registry ID | NCT07589257 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:42:02.760Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07589257
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.